XRN — Stock Film
STOCK FILMSCENE 1/11XRN · $37.03
Stock Expert AI presents
XRN
Chiron Real Estate Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Chiron Real Estate Inc. A quick introduction.

On the stock market since 2016, it operates in the world of real estate. It has 30 employees. Now — the numbers.

on the stock market since 2016
30 employees
$491.1M market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

In the vault right now:
$0
DEBT: $663.7M
At this pace, that money lasts about 2.1 years.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

What executives did with their own stock over the last 12 months:
40 buy0 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
53
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
83
very strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
47
weak

Clearly below the class average.

GROWTH
15
very weak

Clearly below the class average.

PRICE MOMENTUM
57
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
Thin profit on each sale3/10
WORTH WATCHING

Profit per Sale: The profit kept from each sale is thin.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

1
THE BRIGHT SIDE · 1/3
The product is selling

Sales run at $161.0M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 40 buys and 0 sells. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $2.57 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Small scale, thin loss

A loss of $5.8M against $161.0M in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts about 2.1 years. After that, the company needs to find new money.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, XRN sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: XRN is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film